ADA, a potential anti-HIV drug [2]

AIDS Research and Human Retroviruses

Volumn 12, Issue 7, 1996, Pages 567-568

  Vandevelde, M ^a   Witvrouw, M ^a   Schmit, J C ^a   Sprecher, S ^a   De Clercq, E ^a   Tassignon, J P ^a  

^a Hubriphar SPRL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; AZOFORMAMIDE; DIDANOSINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL MODEL; ANTIVIRAL ACTIVITY; CONTROLLED STUDY; DOG; DRUG POTENTIATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; METHEMOGLOBINEMIA; NEPHROLITHIASIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030010446     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.567     Document Type: Letter

References (0)